<DOC>
	<DOCNO>NCT00997932</DOCNO>
	<brief_summary>This prospective clinical trial ultrasound guide intrauterine contraception insertion 10 minute - 48 hour vaginal delivery single infant . A six month follow-up entail three follow-up visit ; 4-6 week , 3 month , 6 month . The objective study measure intrauterine device ( IUD ) expulsion feasibility conduct future clinical trial evaluate placement levonorgestrel-releasing intrauterine contraceptive 10 minute - 48 hour postpartum .</brief_summary>
	<brief_title>A Pilot Study Early Postpartum Intrauterine Contraception</brief_title>
	<detailed_description>This single arm cohort study woman desire receive levonorgestrel release intrauterine system ( LNG-IUS ) within 48 hour uncomplicated vaginal delivery . Women enrol prenatal care visit report desired use LNG-IUS birth infant . Forty woman state enrolled study prior labor , baseline data obtain . After delivery 29 woman remain interested study still eligible receive LNG-IUS prior discharge hospital . Of 29 woman receive LNG-IUS prior discharge hospital 11 woman LNG-IUS expulsion prior 6 month postpartum .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Currently pregnant single gestation least 27 complete week estimate gestational age , complication pregnancy include , limited , preeclampsia , nongestational diabetes , anemia . Desires use intrauterine contraception ( IUD ) delivery Anticipates vaginal delivery No intention leave area 7 month enrollment Able consent participate study English Has know uterine anomaly Has allergies component intrauterine contraception Prior cesarean delivery Having treat pelvic inflammatory disease within 3 month prior start pregnancy Allergic betadine Allergy lidocaine Medical personal condition judgment study staff contradict participation study Any contraindication use levonorgestrelreleasing intrauterine contraceptive system include : know suspect breast carcinoma , acute liver disease liver tumor , history ectopic pregnancy , cervical cancer carcinoma situ After enrollment , delivery infant IUD insertion subject exclude check attend obstetric physician and/or obstetric medical chart following : Endometritis chorioamnionitis intrapartum period Membranes rupture great 24 hour prior delivery Fever great equal 38C The need use additional medication pitocin and/or misoprostol control postpartum bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>levonorgestrel release intrauterine device</keyword>
	<keyword>levonorgestrel release intrauterine contraception</keyword>
	<keyword>unintended pregnancy prevention</keyword>
	<keyword>postpartum contraception</keyword>
</DOC>